Mitsunobu Kano: all publications

• Publications

  • Enhancement of Angiogenesis Through Stabilization of Hypoxia-inducible Factor-1 by Silencing Prolyl Hydroxylase Domain-2 Gene. Molecular therapy : the journal of the American Society of Gene Therapy (2008) (Epub 20 May 2008) PubMed ID:(18500250)

  • Oka M, Iwata C, Suzuki H, Kiyono K, Morishita Y, Watabe T, Komuro A, Kano M, Miyazono K. Inhibition of endogenous TGF-beta signaling enhances lymphangiogenesis. Blood 111 (9) , 4571-9 (2008) (Epub 29 Feb 2008) PubMed ID:(18310502)

  • Iwata C, Kano M, Komuro A, Oka M, Kiyono K, Johansson E, Morishita Y, Yashiro M, Hirakawa K, Kaminishi M, Miyazono K. Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis. Cancer research 67 (21) , 10181-9 (2007) PubMed ID:(17974958)

  • Kano M, Bae Y, Iwata C, Morishita Y, Yashiro M, Oka M, Fujii T, Komuro A, Kiyono K, Kaminishi M, Hirakawa K, Ouchi Y, Nishiyama N, Kataoka K, Miyazono K. Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-beta signaling. Proceedings of the National Academy of Sciences of the United States of America 104 (9) , 3460-5 (Epub 16 Feb 2007) PubMed ID:(17307870 )

  • Kano M, Morishita Y, Iwata C, Iwasaka S, Watabe T, Ouchi Y, Miyazono K, Miyazawa K. VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B-PDGFRbeta signaling. Journal of cell science 118 (Pt 16) , 3759-68 PubMed ID:(16105884)

  • Nakagome K, Dohi M, Okunishi K, Tanaka R, Kouro T, Kano M, Miyazono K, Miyazaki J, Takatsu K, Yamamoto K. IL-5-induced hypereosinophilia suppresses the antigen-induced immune response via a TGF-beta-dependent mechanism. Journal of immunology (Baltimore, Md. : 1950) 179 (1) , 284-94 PubMed ID:(17579048)